The drug failed in this DMD trial. As J.G. said, we don't want to throw the 'baby out with the bath water' until we do further research on the other indications for ATL1102, but at the same time, they are looking for other opportunities.
More news to come in the weeks/month ahead following this webinar on where the Company is heading - hopefully, they get the votes come March 4th and we can get down to business and clear the air in the process!
GLTAH
.
- Forums
- ASX - By Stock
- Ann: Webinar Presentation - Phase IIb study of avicursen
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

The drug failed in this DMD trial. As J.G. said, we don't want...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $727 | 72.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2840316 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3323423 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2840316 | 0.010 |
6 | 5659202 | 0.009 |
4 | 1260267 | 0.008 |
3 | 1642854 | 0.007 |
2 | 3200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 3323423 | 6 |
0.012 | 1139598 | 3 |
0.013 | 1000000 | 1 |
0.014 | 2072000 | 4 |
0.015 | 1500000 | 1 |
Last trade - 12.00pm 20/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |